Navigation Links
PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
Date:4/23/2012

11,300 employees. For more information about PAREXEL International visit www.PAREXEL.com.

This release contains "forward-looking" statements regarding future results and events, including, without limitation, statements regarding expected financial results, future growth and customer demand.
For this purpose, any statements contained herein that are not statements of historical fact may be deemed forward-looking statements.  Without limiting the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "will," "would," "could," "should,"  "targets," and similar expressions are also intended to identify forward-looking statements.  The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings, including the anticipated additional restructuring charges of approximately $2.0 million in the third quarter of Fiscal Year 2012; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharm
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL Announces Date of Third Quarter Fiscal Year 2012 Earnings Release and Conference Call
2. PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting
3. PAREXEL Global Survey Results Identify Top Concerns of Biopharma Industry in Achieving Commercial Success
4. PAREXEL International to Present at Barclays Capital Healthcare Conference
5. PAREXEL International to Present at Cowen Healthcare Conference and Raymond James Investors Conference
6. PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives
7. PAREXEL Expands Alliance Network to Support Early Phase Patient Studies, Establishes Collaboration With University Hospitals Bristol NHS Foundation Trust
8. PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call
9. PAREXEL Strengthens Late Phase and Observational Research Capabilities With Expert Team to Help Biopharma Meet Commercialization Goals
10. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
11. UCB and PAREXEL Sign Strategic Partnership Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... --  West Pharmaceutical Services, Inc. (NYSE: ... injectable drug administration, announced today it plans to expand ... in Waterford, Ireland . The new ... and other high-value packaging components, in order to meet ... this new site could bring approximately 150 new jobs ...
(Date:10/2/2014)... BOSTON , Oct. 1, 2014   Intarcia ... two of its four phase 3 clinical trials for ... through a matchstick-sized, subcutaneous osmotic mini-pump). The first trial, ... that tested the efficacy and safety of ITCA 650 ... study demonstrated ITCA 650 to be significantly superior to ...
(Date:10/1/2014)... Ohio , Oct. 1, 2014 /PRNewswire/ ... shareholders is now available. Interested parties can learn ... how Cardinal Health is supporting the health ... http://cardinalhealth.com/annualreport . Photo- ... to summary financials and the chief executive ...
Breaking Medicine Technology:West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 2West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 3West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 4West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 5Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 2Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 3Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 4Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results 5Cardinal Health 2014 Digital Report to Shareholders Now Available 2
... -- Global Information, Inc. is excited to announce remaining ... scheduled for Boston, MA in the Spring of 2012. ... Drug Design Conference June 6 - ... to arrive at its current mainstream position in medicinal chemistry, ...
... developer of Healthcare Technology Networks ("HTN") designed to improve ... announces the launch of its proprietary Opioid Management Program ... United States Bone & Joint Decade , from ... from musculoskeletal disease filled 1.6 billion prescriptions. While 18.6 ...
Cached Medicine Technology:Boston to Host 3 Major Annual Drug Discovery Conferences, Early Bird Expiring April 27 2Boston to Host 3 Major Annual Drug Discovery Conferences, Early Bird Expiring April 27 3Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP) 2
(Date:10/2/2014)... (PRWEB) October 02, 2014 BamboofloorChina.com is ... its products have won great appreciation from the global ... is working hard to make more excellent items. All ... ready to help all clients. , The company ... panels to its website. Furthermore, the company’s marketing ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. 1, ... personality style and prolonged stress may have a heightened ... Tracking 800 women over nearly four decades, Swedish scientists ... moody -- which they defined as neurotic -- and ... Alzheimer,s compared to women scoring lowest in these traits. ...
(Date:10/2/2014)... may interact with stress to trigger heart disease in some ... in about 13 percent of people, but only in those ... their heart disease risk through simple measures such as ... researchers said. The study authors analyzed genetic data from ... in the EBF1 gene and higher levels of central obesity, ...
(Date:10/2/2014)... Steven Reinberg HealthDay Reporter ... a major highway may raise your risk for high blood ... postmenopausal women, those who lived within 109 yards of a ... high blood pressure than women living at least half a ... study highlight the importance of our physical environment on our ...
(Date:10/2/2014)... By Amy Norton HealthDay ... adults who have trouble smelling the roses -- literally -- may ... new research suggests. In a study of over 3,000 older ... as rose, orange and peppermint were more than three times as ... a sharp sense of smell. In fact, anosmia -- the ...
Breaking Medicine News(10 mins):Health News:High Quality Bamboo Panels Online At BamboofloorChina.com 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 2Health News:Jealous, Moody Women May Face Higher Alzheimer's Risk, Study Says 3Health News:Genes May Make Some More Prone to Heart Disease When Under Stress 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 2Health News:Living Near a Highway May Be Bad for Your Blood Pressure 3Health News:Could a Fading Sense of Smell Point to Earlier Death? 2Health News:Could a Fading Sense of Smell Point to Earlier Death? 3
... Sept. 2 A survey of emergency medical services (EMS) ... of workplace safety cultureproviding a tool that might point to ... of Pittsburgh School of Medicine. The study ... Prehospital Emergency Care and now available online, analyzed survey ...
... Melissa Lee Phillips HealthDay Reporter , WEDNESDAY, Sept. ... mentally stimulating activities have pros and cons when it comes ... prior research, the study finds that such mental activity may ... But folks who loved these pursuits actually displayed a ...
... Sept. 1 (HealthDay News) -- A new study is linking ... non-fatal heart attacks and stroke, although taking the drug did not ... history of heart problems. The finding is stirring mixed reactions ... was funded by Meridia,s maker, Abbott, the findings are generally in ...
... September issue of the Journal of the American Geriatrics ... have a greater risk for dementia than Veterans without PTSD, ... Exposure to life threatening events, like war, can cause PTSD, ... symptoms such as avoiding things or people that remind a ...
... Engineering at Harvard and from Boston University have discovered ... microscopic forms of lifebacteria. Their findings appear in ... studying the development of antibiotic-resistant strains of bacteria, the ... doses of antibiotics are those in which a few ...
... Lee Phillips HealthDay Reporter , WEDNESDAY, Sept. ... inflammation in those with lupus, but the anti-clotting drug ... disease, a new study suggests. Platelets, which are ... clotting, are suspected to be involved in lupus, explained ...
Cached Medicine News:Health News:Safety cultures in EMS agencies vary widely, Pitt study finds 2Health News:Mental 'Exercise' May Only Hide Signs of Alzheimer's 2Health News:Mental 'Exercise' May Only Hide Signs of Alzheimer's 3Health News:Diet Pill Meridia Ups Heart Attack Risk: Study 2Health News:Diet Pill Meridia Ups Heart Attack Risk: Study 3Health News:Pivotal study finds link between PTSD and dementia 2Health News:New research finds evidence of charitable behavior in bacteria 2Health News:Overactive Blood Platelets May Play Role in Lupus 2
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
... The Volk G-1 trabeculum provides the highest ... Perfect for viewing and treating the trabecular meshwork. ... of the anterior chamber angle while the central ... view the posterior pole for signs of glaucoma ...
... The AFX (Air Fluid eXchange) ... lens designed for use in ... to its use as a ... the low profile and sutureless ...
... The 45° Prism ... fundus pathologies and are ... detachments (PDR, BRVO etc.) ... They can be used ...
Medicine Products: